Hoyoung M. Maeng

发表

MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays

E. Ruppin, J. Berzofsky, K. Camphausen, 2022, Cell reports methods.

Strategies for developing and optimizing cancer vaccines

J. Berzofsky, Hoyoung M. Maeng, 2019, F1000Research.

Cancer vaccines: translational strategies

J. Berzofsky, Hoyoung M. Maeng, 2021, Principles of Translational Science in Medicine.

Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy

S. Steinberg, J. Berzofsky, L. Weiner, 2021, Frontiers in Oncology.

Cancer vaccines: translation from mice to human clinical trials.

J. Berzofsky, Hoyoung M. Maeng, M. Terabe, 2018, Current opinion in immunology.

Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity

J. Berzofsky, J. Frelinger, Joyce D. Reyes, 2020, The Journal of Immunology.

Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics

C. Xie, Hoyoung M. Maeng, Xin Wang, 2023, Cells.

Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis.

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2016, Leukemia research.

Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization

Hoyoung M. Maeng, P. Olkhanud, William Becker, 2024, Journal for immunotherapy of cancer.